{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-24-026868","form_type":"8-K","ticker":"HOTH","cik":"0001711786","company_name":"Hoth Therapeutics, Inc.","filed_at":"2024-03-28T23:59:59+00:00","discovered_at":"2026-05-14T18:03:25.208563+00:00","generated_at":"2026-06-04T06:15:39.689414+00:00","sec_items":["1.01","3.02","8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Hoth Therapeutics raises $4.2M via warrant exercise inducement, issues new warrants for 3.75M shares","bullets":["Gross proceeds of ~$4.2M from immediate cash exercise of 2.5M existing warrants at reduced exercise price of $1.6775 (down from $5.00).","Company issues new unregistered warrants to purchase up to 3.75M shares at $1.50, exercisable immediately until July 3, 2028.","Offering expected to close on or about April 1, 2024; H.C. Wainwright acting as exclusive placement agent.","Net proceeds used for general working capital purposes.","Company agreed to file resale registration statement for shares underlying new warrants within 30 days of closing."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-24-026868","json":"https://secwatch.observer/filing/0001213900-24-026868.json","markdown":"https://secwatch.observer/filing/0001213900-24-026868.md","text":"https://secwatch.observer/filing/0001213900-24-026868.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1711786/000121390024026868/0001213900-24-026868-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1711786/000121390024026868/ea0202788-8k_hoththera.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T06:15:39.689414+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"bcdbb3ba997df9172c0e175a831505a224c1bfea","claim":"Hoth Therapeutics, Inc. entered into Inducement Letter with a certain holder of existing warrants valued at aggregate gross proceeds of approximately $4.2 million (effective 2024-03-27).","evidence_excerpt":"On March 27, 2024, Hoth Therapeutics, Inc., a Nevada corporation (the “ Company ”), entered into an inducement offer letter agreement (the “ Inducement Letter ”) with a certain holder (the “ Holder ”) of existing warrants (the “ Existing Warrants ”) to purchase shares of common stock of the Company.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1711786/000121390024026868/0001213900-24-026868-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"a certain holder of existing warrants"},{"label":"Value","value":"aggregate gross proceeds of approximately $4.2 million"},{"label":"Effective","value":"2024-03-27"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}